New developments in cytomegalovirus prevention and management.
暂无分享,去创建一个
[1] T. Merigan,et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.
[2] R. Schooley,et al. SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2 , 1992, Transplantation.
[3] J. Meyers,et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.
[4] J. Bartlett,et al. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis , 1991 .
[5] S. Pauker,et al. Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. , 1991, Transplantation.
[6] R. Milk,et al. Prospective study of cytomegalovirus antigenemia in allograft recipients , 1991, Journal of clinical microbiology.
[7] C. Gross,et al. Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients , 1991, Antimicrobial Agents and Chemotherapy.
[8] E. Petersen. Extrapulmonary cytomegalovirus disease in transplant patients. , 1991, Transplantation proceedings.
[9] H. Friedman,et al. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. , 1991, Annals of internal medicine.
[10] D. Snydman,et al. Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. , 1991, Transplantation proceedings.
[11] T. The,et al. Cytomegalovirus‐specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection , 1991, Clinical and experimental immunology.
[12] M. Ho,et al. Epidemiology of cytomegalovirus infections. , 1990, Reviews of infectious diseases.
[13] S. Chou,et al. Newer methods for diagnosis of cytomegalovirus infection. , 1990, Reviews of infectious diseases.
[14] J. Grundy. Virologic and pathogenetic aspects of cytomegalovirus infection. , 1990, Reviews of infectious diseases.
[15] R. Rubin. Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.
[16] H. Balfour,et al. Management of cytomegalovirus disease with antiviral drugs. , 1990, Reviews of infectious diseases.
[17] D. Snydman,et al. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. , 1990, Reviews of infectious diseases.
[18] Zaia Ja. Epidemiology and pathogenesis of cytomegalovirus disease. , 1990 .
[19] P. Murray,et al. Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. , 1990, The Journal of infectious diseases.
[20] R. Rubin,et al. Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice , 1989, Antimicrobial Agents and Chemotherapy.
[21] F. M. van de Rijke,et al. RAPID DETECTION OF HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF VIREMIC TRANSPLANT RECIPIENTS BY THE POLYMERASE CHAIN REACTION , 1989, Transplantation.
[22] H. Balfour,et al. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. , 1989, The New England journal of medicine.
[23] J. Preiksaitis,et al. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. , 1988, The Journal of infectious diseases.
[24] P. Griffiths,et al. The status of CMV as a human pathogen , 1988, Epidemiology and Infection.
[25] D. Emanuel,et al. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins. , 1987, Bone marrow transplantation.
[26] A. Levey,et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. , 1987, The New England journal of medicine.
[27] W. Britt,et al. Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome , 1987 .
[28] L. Matter,et al. The risk of transmitting cytomegalovirus to patients receiving blood transfusions. , 1986, The Journal of infectious diseases.
[29] F. Logerfo,et al. A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients. , 1984, Transplantation.
[30] M. Hirsch,et al. Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts , 1981 .
[31] R. Rubin,et al. Infection in the renal transplant recipient. , 1981, The American journal of medicine.
[32] C. Prober,et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants , 1981 .
[33] R. Whitley,et al. Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft. , 1980, The Journal of infectious diseases.
[34] G. Monif,et al. Blood as a potential vehicle for the cytomegaloviruses. , 1976, American journal of obstetrics and gynecology.
[35] J. Dowling,et al. Cytomegalovirus Infection in Children Undergoing Open-Heart Surgery 1 , 1976, The Yale journal of biology and medicine.
[36] C. Alford,et al. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. , 1975, The Journal of infectious diseases.
[37] U. Krech,et al. Cytomegalovirus Infections of Man , 1971 .
[38] D. Snydman. Prevention of cytomegalovirus disease with intravenous immune globulin , 1991 .
[39] H. Balfour,et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. , 1991, Transplantation.
[40] W. Weimar,et al. Cytomegalovirus infection and renal transplantation. , 1989, The Journal of antimicrobial chemotherapy.
[41] R. Rubin. Infection in the Renal and Liver Transplant Patient , 1988 .